BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 8212145)

  • 1. Diminution of an acute cyclosporin-induced cholestasis by tauroursodeoxycholate in the rat.
    Queneau PE; Bertault-Perès P; Mesdjian E; Durand A; Montet JC
    Transplantation; 1993 Sep; 56(3):530-4. PubMed ID: 8212145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different protective effects of tauroursodeoxycholate, ursodeoxycholate, and 23-methyl-ursodeoxycholate against taurolithocholate-induced cholestasis.
    Baumgartner U; Schölmerich J; Sellinger M; Reinhardt M; Ruf G; Farthmann EH
    Dig Dis Sci; 1996 Feb; 41(2):250-5. PubMed ID: 8601366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Taurine conjugate of ursodeoxycholate plays a major role in the hepatoprotective effect against cholestasis induced by taurochenodeoxycholate in rats.
    Tsukahara K; Kanai S; Ohta M; Kitani K
    Liver; 1993 Oct; 13(5):262-9. PubMed ID: 8259039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ursodeoxycholate reduces ethinylestradiol glucuronidation in the rat: role in prevention of estrogen-induced cholestasis.
    Sánchez Pozzi EJ; Crocenzi FA; Pellegrino JM; Catania VA; Luquita MG; Roma MG; Rodríguez Garay EA; Mottino AD
    J Pharmacol Exp Ther; 2003 Jul; 306(1):279-86. PubMed ID: 12663690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Difference in the effects of ursodeoxycholate and its taurine conjugate on the biliary excretion of sulfobromophthalein in the rat.
    Kanai S; Kitani K; Sato Y
    J Hepatol; 1990 Mar; 10(2):174-9. PubMed ID: 2332588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvement of cyclosporin A-induced cholestasis by tauroursodeoxycholate in a long-term study in the rat.
    Queneau PE; Bertault-Peres P; Guitaoui M; Mesdjian E; Durand A; Montet JC
    Dig Dis Sci; 1994 Jul; 39(7):1581-5. PubMed ID: 8026273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of oral treatment with ursodeoxycholic and tauroursodeoxycholic acids on estrogen-induced cholestasis in rats: effects on bile formation and liver plasma membranes.
    Bouchard G; Yousef IM; Tuchweber B
    Liver; 1993 Aug; 13(4):193-202. PubMed ID: 8377596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estradiol-17 beta-D-glucuronide (E-17G) cholestasis in perfused rat liver: fate of E-17G and choleretic responses to bile salts.
    Utili R; Tripodi MF; Adinolfi LE; Gaeta GB; Abernathy CO; Zimmerman HJ
    Hepatology; 1990 May; 11(5):735-42. PubMed ID: 2347547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholestatic effects of cyclosporine in the rat.
    Chan FK; Shaffer EA
    Transplantation; 1997 Jun; 63(11):1574-8. PubMed ID: 9197348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bile secretory characteristics of beta-muricholate and its taurine conjugate are similar to those of ursodeoxycholate in the rat.
    Kanai S; Kitani K; Sato Y
    Life Sci; 1991; 48(10):949-57. PubMed ID: 2000026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conjugation is essential for the anticholestatic effect of NorUrsodeoxycholic acid in taurolithocholic acid-induced cholestasis in rat liver.
    Denk GU; Maitz S; Wimmer R; Rust C; Invernizzi P; Ferdinandusse S; Kulik W; Fuchsbichler A; Fickert P; Trauner M; Hofmann AF; Beuers U
    Hepatology; 2010 Nov; 52(5):1758-68. PubMed ID: 21038414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic index of taurocholate or tauroursodeoxycholate in experimental drug-induced cholestasis.
    Utili R; Adinolfi LE; Tripodi MF
    Ital J Gastroenterol; 1995; 27(6):332-4. PubMed ID: 8563000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estradiol-17 beta-glucuronide-induced cholestasis. Effects of ursodeoxycholate-3-O-glucuronide and 3,7-disulfate.
    Sano N; Takikawa H; Yamanaka M
    J Hepatol; 1993 Feb; 17(2):241-6. PubMed ID: 8445238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ursodeoxycholic acid modulates cyclosporin A oral absorption in liver transplant recipients.
    Caroli-Bosc FX; Iliadis A; Salmon L; Macheras P; Montet AM; Bourgeon A; Garraffo R; Delmont JP; Montet JC
    Fundam Clin Pharmacol; 2000; 14(6):601-9. PubMed ID: 11206711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Taurohyocholate, taurocholate, and tauroursodeoxycholate but not tauroursocholate and taurodehydrocholate counteract effects of taurolithocholate in rat liver.
    Schölmerich J; Kitamura S; Baumgartner U; Miyai K; Gerok W
    Res Exp Med (Berl); 1990; 190(2):121-9. PubMed ID: 2349395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of bile salt infusion on chlorpromazine-induced cholestasis in the isolated perfused rat liver.
    Utili R; Tripodi MF; Abernathy CO; Zimmerman HJ; Gillespie J
    Proc Soc Exp Biol Med; 1992 Jan; 199(1):49-53. PubMed ID: 1728036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of tauroursodeoxycholate on actin filament alteration induced by cholestatic agents. A study in isolated rat hepatocyte couplets.
    Thibault N; Maurice M; Maratrat M; Cordier A; Feldmann G; Ballet F
    J Hepatol; 1993 Nov; 19(3):367-76. PubMed ID: 8151096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lithocholate-3-O-glucuronide-induced cholestasis. A study with congenital hyperbilirubinemic rats and effects of ursodeoxycholate conjugates.
    Takikawa H; Minagawa K; Sano N; Yamanaka M
    Dig Dis Sci; 1993 Aug; 38(8):1543-8. PubMed ID: 8344113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ursodeoxycholate alleviates alcoholic fatty liver damage in rats.
    Oliva L; Beaugé F; Choquart D; Montet AM; Guitaoui M; Montet JC
    Alcohol Clin Exp Res; 1998 Oct; 22(7):1538-43. PubMed ID: 9802540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of curcumin on cyclosporine-induced cholestasis and hypercholesterolemia and on cyclosporine metabolism in the rat.
    Deters M; Klabunde T; Meyer H; Resch K; Kaever V
    Planta Med; 2003 Apr; 69(4):337-43. PubMed ID: 12709901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.